Opposition by federal regulators to Amgen's announced $27.8 billion buyout of Horizon Therapeutics raises questions about how solidly merger-and-acquisition (M&A) activity will bounce back from pandemic lows this year.
StockWatch: FTC vs Amgen-Horizon Could Slam Brakes on Biotech M&A genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Geroscience Gains Traction in Addressing Age-Related Diseases genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.